Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
Researchers have recently demonstrated that an oncogenic mutation (R110) in the immunoglobulin light-chain variable region (IGLV) is an important and widespread indicator of poor prognosis in chronic lymphocytic leukemia (CLL).